1. Study details.
Study ID | First author, year of publication |
Patient sampling | Prospective/retrospective, case‐control/consecutive/random patient series |
Patient characteristics and setting | Inclusion and exclusion criteria, previous tests for lung cancer (diagnosis and staging), clinical setting, sample size, age, sex, comorbidities, country, histology of primary tumour |
Index test | Details of the index test used including the type of PET‐CT scanner, FDG dose, injection‐to‐scan time, attenuation correction, and the cut‐off values for test positivity (malignancy) |
Reference standard(s) | The reference standard(s) used |
Flow and timing | All participants were accounted for in results, missing/uninterpretable test results, reasons for withdrawal, adverse events caused by test, the time interval, and any interventions between index test(s) and reference standard |
Notes | Source of funding, anything else of relevance |
FDG = (¹⁸F)‐2‐fluoro‐deoxy‐D‐glucose. PET‐CT = positron emission tomography and computed tomography.